• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule

expresspharmaDecember 13, 2021

Tag: Cariprazine , Zydus , Capsule

Zydus Pharmaceuticals Inc has received tentative approval from the United States Food and Drug Administration (FDA) to market Cariprazine Capsules in the strengths of 1.5 mg, 3 mg, 4.5 mg and 6 mg, the company notified via a statement.

It also said that Cariprazine is an atypical antipsychotic. Zydus’ Cariprazine Capsules are indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar disorder. The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

Previous:Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Next:Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

High Precision Mould for Soft Capsules

High Precision Mould for Soft Capsules
Gestrinone Capsules

Gestrinone Capsules
Magnesium Capsule

Magnesium Capsule
shilajit capsules

shilajit capsules
Shilajit Ginseng Capsule

Shilajit Ginseng Capsule
Pancreatin Enteric Capsules

Pancreatin Enteric Capsules
Nitric oxide supplements capsule

Nitric oxide supplements capsule
Auto Inspection Machine for Empty Capsules Model CI5S

Auto Inspection Machine for Empty Capsules Model CI5S
HPMC vegetable capsule size 1

HPMC vegetable capsule size 1
Hard capsules

Hard capsules

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service